Prolonged-release buprenorphine formulations: Perspectives for clinical practice.
Sign Up to like & getrecommendations! Published in 2020 at "Therapie"
DOI: 10.1016/j.therap.2020.05.007
Abstract: Buprenorphine and methadone are the two main opioid agonist treatments approved for opioid use disorder. Buprenorphine is a partial agonist of the mu opioid receptors, which has been merely available through sublingual form until now.… read more here.
Keywords: release buprenorphine; sublingual buprenorphine; prolonged release; practice ... See more keywords
[Prolonged-release buprenorphine formulations: Perspectives for clinical practice].
Sign Up to like & getrecommendations! Published in 2020 at "Therapie"
DOI: 10.1016/j.therap.2020.05.008
Abstract: Buprenorphine and methadone are the two main opioids agonist treatments approved for opioid use disorder. Buprenorphine is a partial agonist of the mu-opioid receptors, which has been merely available through sublingual form until now. In… read more here.
Keywords: release buprenorphine; sublingual buprenorphine; prolonged release; practice ... See more keywords
Using Extended Release Buprenorphine Injection to Discontinue Sublingual Buprenorphine: A Case Series.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of addiction medicine"
DOI: 10.1097/adm.0000000000000738
Abstract: : Buprenorphine is highly effective for the treatment of opioid use disorder and is increasingly being used in the treatment of chronic pain. For various reasons, patients on buprenorphine may request discontinuation of this medication.… read more here.
Keywords: release buprenorphine; sublingual buprenorphine; injection; extended release ... See more keywords
A Case of Acute Opioid Withdrawal after Liposuction Surgery in a Patient on Extended-release Buprenorphine.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of addiction medicine"
DOI: 10.1097/adm.0000000000001172
Abstract: BACKGROUND The US Food and Drug Administration approved the once-monthly injectable extended-release buprenorphine product to treat moderate-to-severe opioid use disorders. The patient in our case report had a liposuction procedure and immediately started having opioid… read more here.
Keywords: withdrawal; buprenorphine; opioid withdrawal; extended release ... See more keywords
The Social, Material, and Temporal Effects of Monthly Extended-Release Buprenorphine Depot Treatment for Opioid Dependence: An Australian Qualitative Study
Sign Up to like & getrecommendations! Published in 2022 at "Contemporary Drug Problems"
DOI: 10.1177/00914509221140959
Abstract: Aims: This study examined the social, material and temporal effects of extended-release buprenorphine depot treatment (BUP-XR), among a group of participants commencing BUP-XR in Australia, and considered the situated potentials of these new opioid agonist… read more here.
Keywords: release buprenorphine; material temporal; temporal effects; extended release ... See more keywords
Perioperative Management of Extended-Release Buprenorphine: A Narrative Review and Case Series
Sign Up to like & getrecommendations! Published in 2023 at "Substance Abuse"
DOI: 10.1177/08897077231167043
Abstract: Background: Perioperative management of formulations of buprenorphine used for the treatment of opioid use disorder and/or pain are common clinical challenges. Care strategies are increasingly recommending continuation of buprenorphine while administering multimodal analgesia including full… read more here.
Keywords: extended release; release buprenorphine; buprenorphine; perioperative management ... See more keywords
Sustained release buprenorphine effectively attenuates postoperative hypersensitivity in an incisional pain model in neonatal rats (Rattus norvegicus).
Sign Up to like & getrecommendations! Published in 2021 at "PloS one"
DOI: 10.1371/journal.pone.0246213
Abstract: Despite the need for safe and effective postoperative analgesia in neonates, research regarding pain management in neonatal rodents is relatively limited. Here, we investigate whether sustained release buprenorphine (Bup SR) effectively attenuates thermal hypersensitivity in… read more here.
Keywords: effectively attenuates; thermal hypersensitivity; release buprenorphine; sustained release ... See more keywords
Effectiveness of two extended-release buprenorphine formulations during postoperative period in neonatal rats
Sign Up to like & getrecommendations! Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0276327
Abstract: Information on the effectiveness of a new long-lasting buprenorphine formulation, extended-release buprenorphine, in the neonatal rat is very limited. This study compares whether a high dose of extended-release buprenorphine (XR-Hi) attenuates thermal hypersensitivity for a… read more here.
Keywords: period; thermal hypersensitivity; buprenorphine; extended release ... See more keywords